Martin L. Yarmush, M.D., Ph.D.
Presentation: Human-Relevant Microfluidic Devices and Cell Cultures
Martin L. Yarmush is an internationally recognized bioengineer and biophysical chemist whose laboratory has been a leader in the fields of tissue engineering and regenerative medicine, BioMEMS and nanotechnology, and applied immunology. Dr. Yarmush currently serves as the Paul and Mary Monroe Professor of Science and Engineering and Distinguished Professor of Biomedical Engineering at Rutgers University, and the director of the Center for Engineering in Medicine at the Massachusetts General Hospital. He also serve as the chief academic adviser for HμREL Corporation, which aims to develop patented in vitro cell and tissue cultures and microfluidic devices that constitute superior tools with regard to metabolic competency and stability, and that may eventually replace animal testing. Over the last 25 years, Dr. Yarmush has published more than 400 journal articles, has mentored over 120 postdoctoral fellows and graduate students, and has co-authored more than 30 patents and patent applications. A frequent invited speaker at major conferences and symposia, and winner of over 30 local and national awards, Dr. Yarmush is known as one of the leading investigators in the area of multiscale bioengineering through seminal contributions to the fields of tissue engineering and regenerative medicine, BioMEMS, applied immunology, metabolic engineering, and genomics and proteomics technologies. Dr. Yarmush received his bachelor’s degrees from Yeshiva University, his medical degree from Yale University, and completed doctoral work at The Rockefeller University (physical biochemistry) and MIT (Chemical Engineering).